Inicio › Cáncer de hígado (carcinoma hepatocelular) › Massachusetts › Boston
Ensayos clínicos de Cáncer de hígado (carcinoma hepatocelular) en Boston, MA
18 estudios para Cáncer de hígado (carcinoma hepatocelular) buscan participantes en centros de Boston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ReclutandoFase 1
- Exelixis Clinical Site #7, Boston
National Liver Cancer Screening Trial
ReclutandoFase 4
- Massachusetts General Hospital, Boston
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
ReclutandoFase 1
- Mass General Cancer Center, Boston
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
ReclutandoFase 2
- Massachusetts General Hospital, Boston
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
ReclutandoEstudio observacional
- Mass General Brigham, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- Dana-Farber Cancer Institute, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
ReclutandoFase 3
- Massachusetts General Hospital Cancer Center, Boston
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
ReclutandoFase 1/2
- Research Site, Boston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ReclutandoFase 2
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
ReclutandoFase 1/2
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Reclutando
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
ReclutandoFase 1
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
Computer Guided Microwave Liver Ablation
Reclutando
- Massachusetts General Hospital, Boston
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
ReclutandoFase 2
- Children's Hospital Boston, Boston
- Dana Farber Cancer Institute, Boston
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
ReclutandoFase 4
- Massachussets General Hospital, Boston
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
ReclutandoEstudio observacional
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown · A 1 mi de distancia
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
Reclutando
- Massachusetts General Hospital, Boston
Ensayos de Cáncer de hígado (carcinoma hepatocelular) en otras ciudades
- Houston, TX31 estudios
- New York City, NY24 estudios
- Dallas, TX19 estudios
- Los Angeles, CA19 estudios
- Cleveland, OH18 estudios
- Philadelphia, PA16 estudios
- Chicago, IL16 estudios
- Pittsburgh, PA15 estudios
- San Francisco, CA14 estudios
- Orange, CA14 estudios
- Jacksonville, FL14 estudios
- San Antonio, TX13 estudios
Otros estudios en Boston
- Cáncer de seno112 estudios
- Cáncer de pulmón de células no pequeñas90 estudios
- Cáncer (todos los tipos)85 estudios
- Cáncer metastásico63 estudios
- Cáncer del colon y del recto63 estudios
- Cáncer de pulmón62 estudios
- Cáncer de ovario61 estudios
- Cáncer de próstata59 estudios
- Depresión52 estudios
- Cáncer de endometrio50 estudios
- Fallo cardíaco44 estudios
- Leucemia mielógena aguda44 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.